HMGCR and hyperlipidemia: To examine whether therapeutics for hyperlipidemia can reduce the plasma cholesterol level in LDLR KO monkeys, we first administrated 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, statins21, in LDLR KO monkeys.